Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
Schjerning Olsen, Anne-Marie; Fosbøl, Emil L; Lindhardsen, Jesper; Folke, Fredrik; Charlot, Mette; Selmer, Christian; Lamberts, Morten; Bjerring Olesen, Jonas; Køber, Lars; Hansen, Peter R; Torp-Pedersen, Christian; Gislason, Gunnar H.
; 123(20): 2226-35, 2011 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-21555710
Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk.
Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis.
NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
Beta-blockers for suspected or diagnosed acute myocardial infarction.
Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
Single-dose intravenous diclofenac for acute postoperative pain in adults.
A systematic review and meta-analysis of oxaceprol in the management of osteoarthritis: An evidence from randomized parallel-group controlled trials.
Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
Topical NSAIDs for chronic musculoskeletal pain in adults.
Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.